PATRUSSI LAURA | Professor page

Finetti, F., Zevolini, F., Migliore, L., Cianfanelli, V., Marzuoli, L., Capitani, N., et al. (2025). IFT20 regulates TFEB-dependent lytic granule biogenesis in cytotoxic T lymphocytes by orchestrating the MPR-dependent transport of granzyme B. CELL DEATH & DISEASE, 16(1) [10.1038/s41419-025-07727-5]. - view more
Cassioli, C., Capitani, N., Staton, C.c., Schirra, C., Finetti, F., Onnis, A., et al. (2025). Activation-induced thrombospondin-4 works with thrombospondin-1 to build cytotoxic supramolecular attack particles. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 122(6) [10.1073/pnas.2413866122]. - view more
Rossi, S., Tatangelo, V., Dichiara, M., Butini, S., Gemma, S., Brogi, S., et al. (2024). A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients. BIOMÉDECINE & PHARMACOTHÉRAPIE, 174 [10.1016/j.biopha.2024.116537]. - view more
Lopresti, L., Capitani, N., Tatangelo, V., Tangredi, C., Boncompagni, G., Frezzato, F., et al. (2024). p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 12 [10.3389/fcell.2024.1297116]. - view more
Lopresti, L., Tatangelo, V., Baldari, C.T., Patrussi, L. (2024). Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy. FRONTIERS IN IMMUNOLOGY, 15 [10.3389/fimmu.2024.1418527]. - view more

All publications